1D–F) with a size ranging from 60 to 80 nm, as described earlier [26] and [27]. Relaxed eicosahedric structures, presumably VLPs, were observed in groups close to the cytoplasmic membrane or contained in vesicles. In order to study the correct expression of the pIPNV-PP vaccine in vivo, we first studied the expression of the vaccine in the muscle NSC 683864 solubility dmso of injected rainbow trout at days 2, 7 and 14 post-vaccination, comparing it to the level of expression of the VHSV DNA vaccine
pMCV1.4-G ( Fig. 2). As expected, no transcription of either VHSV G or IPNV VP2 genes were observed in the muscle of rainbow trout vaccinated with the empty plasmids (control), whereas their correct transcription was detected, at similar levels, through semi-quantitative PCR in the muscle of vaccinated fish
at all the time points studied. Comparison of the expression levels of different immune-relevant genes in fish vaccinated with this website either the pIPNV-PP or the VHSV pMCV1.4-G DNA vaccine, were performed through real-time PCR in muscle, head kidney and spleen of vaccinated rainbow trout at days 2, 7 and 14 post-vaccination. Concerning the expression of antigen-presenting genes, MCH Iα and MCH IIα, the pIPNV-PP vaccine significantly up-regulated the MCH Iα gene in spleen at days 2 and 14 post-injection, whilst the MCH IIα gene was only increased after 2 days in both head kidney and spleen (Fig. 3). On the other hand, the VHSV DNA vaccine induced a significant up-regulation at day 14 of MCH Iα gene in head kidney and spleen and of the MCH IIα gene in head kidney. Surprisingly, some unpredicted Rutecarpine down-regulations were also observed for both vaccines. The effects of either of the two DNA vaccines on the levels of expression of genes related to type-I IFN were also quite different (Fig. 4). The IPNV vaccine only increased IFN gene expression in spleen after 7 days of vaccination whilst the VHSV G vaccine up-regulated it in both head kidney and spleen at 14 and 7 days post-vaccination, respectively. Mx gene expression was up-regulated in head kidney at days 2 and 7 post-vaccination and in the spleen at day 2
post-vaccination. On the other hand, the VHSV DNA vaccine up-regulated Mx gene expression in muscle, head kidney and spleen at days 7 and 14 post-vaccination. As indicators of cellular specific immune responses, we also studied the effect that both vaccines had on the levels of transcription of IFN-γ, CD4 and CD8α (Fig. 5). The IPNV vaccine had no stimulatory effect on IFN-γ transcript levels even decreasing its levels of expression in the spleen at day 2 post-vaccination while the VHSV DNA vaccine significantly induced the levels of IFN-γ in both the head kidney and spleen. Concerning the markers for T-lymphocyte subsets, CD4 and CD8, strong differences between the effects induced by the two vaccines were observed. While pIPNV-PP had a moderate up-regulation of CD4 mRNA levels in the muscle the pMCV1.
No related posts.